A multicenter prospective observational study for health assessment questionnaires EQ-5D-5L and G8 in unresectable advanced pancreatic cancer treated with first-line gemcitabine plus nab-paclitaxel therapy

• DOI: 10.1007/s10147-025-02717-1
• Publication Date: 2025-02-27T01:57:36Z
• Authors: Kaori Hino; Tomohiro Nishina; Mitsuhito Koizumi; Kaori Marui; Masahito Kokubu; Yuki Numata; Yoshiki Imamura; Kozue Kanemitsu-O...; Toru Otsuru; Taira Kuroda; Yoshinori Ohno; Akinori Asagi; Hideki Miyata; Tomoyuki Yokota; Teru Kumagi; Ichinosuke Hyodo; Yoshio Ikeda; Yoichi Hiasa
• Keywords: Surgical oncology; Nab-paclitaxel